Global cancer burden, growing amidst mounting need for services. WHO. https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services. Accessed 19 Jan 2024.

International Agency for Research on Cancer: All cancers. https://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf. Accessed 19 Jan 2024.

Siegel RL, Miller KD, Wagle NS, et al. CA: A Cancer Journal for Clinicians. Cancer Stat. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.

Article  Google Scholar 

Berger NA, Savvides P, Koroukian SM, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc 2006;147–156

WHO Model List of Essential Medicines: 20th List (April 2017). 26–31. http://www.who.int/medicines/publications/essentialmedicines/en/. Accessed 19 Jan 2023.

Dahan R. Monoclonal antibodies, antibody-drug conjugates, and specific antibodies. Cancer Research Institute. https://www.cancerresearch.org/immunotherapy/treatment-types/targeted-antibodies. Accessed 19 Jan 2024.

Types of cancer treatment. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types. Accessed 20 Jan 2024.

National Cancer Institute (NCI). Immunotherapy to treat cancer. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy. Accessed 20 Jan 2024.

Tran E, Robbins PF, Lu Y-C, et al. T-cell transfer therapy targeting mutant KRAS in cancer. Engl J Med. 2016;375(23):2255–62.

Article  CAS  Google Scholar 

DeMaria PJ, Bilusic M. Cancer Vaccines. Hematol Oncol Clin North Am. 2019;33(2):199–214.

Article  PubMed  Google Scholar 

Almost half of oncology drugs approved since 1998 have been Precision therapies, new study shows. The ASCO Post staff. 10/19/2023. https://ascopost.com/news/october-2023/almost-half-of-oncology-drugs-approved-since-1998-have-been-precision-therapies-new-study-finds/. Accessed 1 Feb 2024.

Manis JP. Overview of therapeutic monoclonal antibodies, in UpToDate ed Furst DE, Nov 2020

Baldo BA. Monoclonal antibodies approved for cancer therapy in Safety of Biologics Therapy. Cham: Springer, 2016;57–140.

DeMaria PJ, Bilusic M. Cancer Vaccines. Op. Cit

American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2019–2021. Atlanta: American Cancer Society; 2019. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2019-2021.pdf. Accessed 1 Feb 2024.

Guidelines International Network. https://guidelines.ebmportal.com/guidelines-international-network?search=cancer&type=search. Accessed 1 Feb 2024.

Balducci L, Cohen HJ, Engstrom PF, et al. Senior adult oncology clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005;3(4):572–90.

Article  PubMed  Google Scholar 

Grilli R, Magrini N, Penna A, et al. Practice guidelines developed by specialty societies: the need for critical appraisal. The Lancet. 2000;355(9198):103–6.

Article  CAS  Google Scholar 

ESMO Clinical Practice Guidelines. https://www.esmo.org/guidelines. Accessed 1 Feb 2024.

National Comprehensive Cancer Network. NCCN Guidelines & Clinical Resources: NCCN Guidelines. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed 15 Feb 2024.

Institute of Medicine. Dying in America: Improving quality and honoring individual preferences near the end of life. Washington, DC: National Academies Press; 2014.

Google Scholar 

The World Health Organization Quality of Life (WHOQOL). https://www.who.int/toolkits/whoqol. Accessed 15 Feb 2024.

Caring for someone in their last days and hours: Marie Curie. https://www.mariecurie.org.uk/professionals/palliative-care-knowledge-zone/final-days/caring-last-days. Accessed 1 Mar 2024.

Approaching death: Improving care at the End of Life. Institute of Medicine (US) Committee on Care at the End of Life; Field MJ, Cassel CK, editors. Washington (DC): National Academies Press (US); 1997. https://www.ncbi.nlm.nih.gov/books/NBK233591/. Accessed 1 Mar 2024.

End-of-Life care for people who have cancer. NCI. https://www.cancer.gov/about-cancer/advanced-cancer/care-choices/care-fact-sheet. Accessed 1 Mar 2024.

Making decisions and managing your treatment: If cancer treatments stop. Am Cancer Soc. https://www.cancer.org/treatment/treatments-and-side-effects/planning-managing/if-cancer-treatments-stop-working.html. Accessed 8 Mar 2024.

NCCN Guidelines & Clinical Resources: NCCN guidelines for supportive care. http://www.nccn.org/professionals/physician_gls/PDF/palliative.pdf. Accessed 8 Mar 2024.

Guidelines, Tools, & Resources. ASCO. https://www.asco.org/research-guidelines/quality-guidelines/guidelines. Accessed 8 Mar 2024.

NCCN Recently Updated Guidelines: Supportive care, 2024. https://www.nccn.org/guidelines/category_3. Accessed 8 Mar 2024.

Jacobsen J, Jackson VA. A communication approach for Oncologist: Understanding patient coping and communicating about bad news, Palliative care, and Hospice. J Natl Compr Canc Netw. 2009;7(4):475–80.

Article  PubMed  Google Scholar 

Li Mo, Urbauer DL, Bruera E, et al. Recommendations for palliative and hospice care in NCCN Guidelines for Treatment of Cancer. The Oncologist. 2021;26:77–83.

Article  Google Scholar 

Zaman S, Inbadas H, Whitelaw A, et al. Common or multiple futures for end-of-life care around the world: Ideas from the ‘waiting room of history.’ Soc Sci Med. 2017;172:72–9.

Article  PubMed  PubMed Central  Google Scholar 

Stevens J. A pathway to euthanasia? Family revives father doctors ruled wasn’t worth saving. Daily Mail; Feb 13, 2013 http://www.dailymail.co.uk/news/article-2217061/Liverpool-Care-Pathway-Family-revive-man-doctors-wasnt-worth-savinghtml. Accessed 8 Mar 2024.

More care, less pathway: A review of the Liverpool Care Pathway: Department of Health, London, 2013. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/212450/Liverpool_Care_Pathway.pdf. Accessed 8 Mar 2024.

Wikipedia contributors. Death panel. Wikipedia, The Free Encyclopedia. 2020. https://en.wikipedia.org/w/index.php?title=Death_panel&oldid=992320301. Accessed 9 Mar 2024.

Faguet GB. The affordable care act: A missed opportunity. A better way forward: Algora Publishing; 2013.

Google Scholar 

History of the Aktion T4: Nazi program for involuntary euthanasia; The murder of thousands of disabled and psychiatric patients, 2020. https://www.normandy1944.info/holocaust/aktion-t4. Accessed 9 Mar 2024.

Malin JL. Bridging the divide: Integrating cancer-directed therapy and palliative care. J Clin Oncol. 2004;22(17):3438–40.

Article  PubMed  Google Scholar 

Bekelman JE, Halpern SD, Blankart CR, et al. Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with Cancer in 7 developed countries. JAMA. 2016;315(3):272–83.

Article  PubMed  CAS  Google Scholar 

Tang ST, Wu S-C, Hung Y-N, et al. Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000–2006. Ann Oncol. 2009;20(2):343–8.

Article  PubMed  CAS  Google Scholar 

Lee HS, Chun KH, Moon D, et al. Trends in receiving chemotherapy for advanced cancer patients at the end of life. BMC Palliat Care. 2015;14:4.

Article  PubMed  PubMed Central  Google Scholar 

Chastek B, Harley C, Kallich J, et al. J Oncol Pract. 2012;8(6):75s–80s.

Article  PubMed  PubMed Central  Google Scholar 

Vestergaard AHS, Neergard MA, Christiansen CF, et al. Hospitalization at the end of life among cancer and non-cancer patients in Denmark: A nationwide register-based cohort study. BMJ Open. 2020;10:e033493.

Article  PubMed  PubMed Central  Google Scholar 

Merchant SJ, Lajkosz K, Brody SB, et al. The final 30 days of life: A study of patients with gastrointestinal cancer in Ontario. Canada J Palliat Care. 2017;32(3–4):92–100.

Article  PubMed  Google Scholar 

Egan PC, LeBlanc Olszewski TW. End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies. Blood Adv. 2020;4(15):3606–14.

Article  PubMed  PubMed Central  Google Scholar 

Gomes B, Calanzani N, Gysels M, et al. Heterogeneity and changes in preferences for dying at home: a systematic review. BMC Palliat Care. 2013;12:7.

Article  PubMed  PubMed Central  Google Scholar 

Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21(6):1133–8.

Article  PubMed  Google Scholar 

Lamont EB, Christakis NA. Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med. 2001;134(12):1096–10105.

Article  PubMed  CAS  Google Scholar 

Gorman TE, Ahern SP, Wiseman J, et al. Residents’ end-of-life decision making with adult hospitalized patients: a review of the literature. Acad Med. 2005;80:622–33.

Article  PubMed  Google Scholar 

Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, editor. Evaluation of Chemotherapeutic Agents. New York, NY: Columbia University Press; 1949. p. 191–205.

Google Scholar 

Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–55.

Article  PubMed  CAS  Google Scholar 

Soares da Silva L, Rocha S, Riechelmann RP. Treatment of patients with metastatic colorectal cancer and poor performance and status: current evidence and challenges. Clinics (Sao Paulo). 2018;73(1):e542s.

Google Scholar 

Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.

Article  PubMed  CAS  Google Scholar 

Guerra-Farfan E, Garcia-Sanchez Y, Jornet-Gilbert M, et al. Clinical practice guidelines: Thee good, the bad, and the ugly. 2023. https://www.sciencedirect.com/science/article/abs/pii/S0020138322000778. Accessed 1 May 2024.

Braga S. Why do our patients get chemotherapy until the end of life? Ann Oncol. 2011;22:2345–8.

Article  PubMed  CAS  Google Scholar 

Khatcheressian J, Harrington SB, Lyckholm LJ, et al. ‘Futile Care’: What to do when your patient insists on chemotherapy that likely won’t help. Oncology. 2008;22(8):881–8.